Sudarshan Pharma Industries Limited (BOM:543828)
India
· Delayed Price · Currency is INR 24.91
-0.38 (-1.50%)
At close: Mar 9, 2026
BOM:543828 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 159.55 | 114.55 | 70.37 | 52.48 | 26.71 | Upgrade
|
| Depreciation & Amortization | - | 10.3 | 12.29 | 9.07 | 8.66 | 6.24 | Upgrade
|
| Other Amortization | - | 2.84 | - | - | - | 1.19 | Upgrade
|
| Other Operating Activities | - | 201.01 | 96.16 | 52.66 | 33 | 32.63 | Upgrade
|
| Change in Accounts Receivable | - | -365.52 | -415.71 | -80.33 | -130.83 | -335.19 | Upgrade
|
| Change in Inventory | - | -526.75 | -97.98 | -276.98 | -229.06 | -65.87 | Upgrade
|
| Change in Accounts Payable | - | 279.68 | -332.55 | 181.38 | 295.33 | 277.81 | Upgrade
|
| Change in Other Net Operating Assets | - | 587.95 | 720.09 | -244.11 | -67.8 | 84.38 | Upgrade
|
| Operating Cash Flow | - | 349.06 | 96.86 | -287.93 | -38.22 | 27.9 | Upgrade
|
| Operating Cash Flow Growth | - | 260.39% | - | - | - | 317.81% | Upgrade
|
| Capital Expenditures | - | -46.93 | -37.84 | -143.27 | -16.56 | -13.2 | Upgrade
|
| Cash Acquisitions | - | -0.73 | -29.97 | - | - | - | Upgrade
|
| Investment in Securities | - | -164.99 | -15 | -123.39 | - | - | Upgrade
|
| Other Investing Activities | - | 10.23 | -8.03 | 10.14 | 1.99 | 0.25 | Upgrade
|
| Investing Cash Flow | - | -202.42 | -90.84 | -256.52 | -14.57 | -12.95 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 78.49 | 12.03 | 12.11 | Upgrade
|
| Long-Term Debt Repaid | - | -0.31 | -22.97 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -0.31 | -22.97 | 78.49 | 12.03 | 12.11 | Upgrade
|
| Issuance of Common Stock | - | - | - | 641.61 | 20.19 | - | Upgrade
|
| Common Dividends Paid | - | - | -7.22 | - | - | - | Upgrade
|
| Other Financing Activities | - | -143.76 | -91.63 | -60.82 | 10.38 | -27.2 | Upgrade
|
| Financing Cash Flow | - | -144.07 | -121.82 | 659.28 | 42.61 | -15.09 | Upgrade
|
| Net Cash Flow | - | 2.57 | -115.8 | 114.83 | -10.19 | -0.14 | Upgrade
|
| Free Cash Flow | - | 302.13 | 59.02 | -431.2 | -54.79 | 14.7 | Upgrade
|
| Free Cash Flow Growth | - | 411.94% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | 5.98% | 1.27% | -9.35% | -1.53% | 0.76% | Upgrade
|
| Free Cash Flow Per Share | - | 1.25 | 0.25 | -1.79 | -0.38 | 0.10 | Upgrade
|
| Cash Interest Paid | - | 154.71 | 90.28 | 54.02 | 33.79 | 32.25 | Upgrade
|
| Cash Income Tax Paid | - | 28.41 | 21.22 | 21.06 | 17.68 | 8.41 | Upgrade
|
| Levered Free Cash Flow | - | -521.19 | -731.33 | -447.11 | -89.26 | -98.4 | Upgrade
|
| Unlevered Free Cash Flow | - | -433.03 | -682.14 | -418.45 | -72.02 | -80.55 | Upgrade
|
| Change in Working Capital | - | -24.65 | -126.15 | -420.03 | -132.35 | -38.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.